VIVO
Meridian Bioscience Inc
$33.97
Earnings Summary
Revenue | $65.68Mn |
Net Profits | $5.71Mn |
Net Profit Margins | 8.69% |
Highlights
Meridian Bioscience Inc’s revenue fell -13.82% since last year same period to $65.68Mn in the Q3 2022. On a quarterly growth basis, Meridian Bioscience Inc has generated -3.09% fall in its revenue since last 3-months.
Meridian Bioscience Inc’s net profit fell -14.3% since last year same period to $5.71Mn in the Q3 2022. On a quarterly growth basis, Meridian Bioscience Inc has generated 177.75% jump in its net profits since last 3-months.
Meridian Bioscience Inc’s net profit margin fell -0.56% since last year same period to 8.69% in the Q3 2022. On a quarterly growth basis, Meridian Bioscience Inc has generated 180.23% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Meridian Bioscience Inc post its latest quarter earnings
EPS Estimate Current Quarter | 0.2 |
EPS Estimate Current Year | 0.2 |
Highlights
Meridian Bioscience Inc’s earning per share (EPS) estimates for the current quarter stand at 0.2 - a 33.33% jump from last quarter’s estimates.
Meridian Bioscience Inc’s earning per share (EPS) estimates for the current year stand at 0.2.
Key Ratios
Key ratios of the Meridian Bioscience Inc post its Q3 2022 earnings
Earning Per Share (EPS) | 0.21 |
Highlights
Meridian Bioscience Inc’s earning per share (EPS) fell -12.5% since last year same period to 0.21 in the Q3 2022. This indicates that the Meridian Bioscience Inc has generated -12.5% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2022-08-05 | 0.16 | 0.16 | 0% |
2022-11-22 | 0.15 | 0.21 | 40% |
2022-05-06 | 0.48 | 0.66 | 37.5% |
₹0 US Stocks a/c Opening Fee